Effects of Serelaxin in Patients with Acute Heart Failure | Zendy

Marco Metra | Zendy; John R. Teerlink | Zendy; Gad Cotter | Zendy; Beth A. Davison | Zendy; G. Michael Felker | Zendy; Gerasimos Filippatos | Zendy; Barry Greenberg | Zendy; Peter S. Pang | Zendy; Piotr Ponikowski | Zendy; Adriaan A. Voors | Zendy; Kirkwood F. Adams | Zendy; Stefan D. Anker | Zendy; Alexandra AriasMendoza | Zendy; Patricio Avendaño | Zendy; Fernando Bacal | Zendy; Michael Böhm | Zendy; Guillermo Bortman | Zendy; John G.F. Cleland | Zendy; Alain CohenSolal | Zendy; María G. CrespoLeiro | Zendy; Maria Dorobanţu | Zendy; Luis Eduardo Echeverría | Zendy; Roberto Ferrari | Zendy; Sorel Goland | Zendy; Eva Gonçalvesová | Zendy; Assen Goudev | Zendy; Lars Køber | Zendy; Juan Lema-Osores | Zendy; Phillip D. Levy | Zendy; Kenneth McDonald | Zendy; Pravin Manga | Zendy; Béla Merkely | Zendy; Christian Mueller | Zendy; Burkert Pieske | Zendy; José SilvaCardoso | Zendy; Jindřich Špinar | Zendy; Iain Squire | Zendy; Janina Stępińska | Zendy; W. Van Mieghem | Zendy; Dirk von Lewinski | Zendy; Gerhard Wikström | Zendy; Mehmet Birhan Yılmaz | Zendy; Nicole Hagner | Zendy; Thomas Holbro | Zendy; Tsushung A. Hua | Zendy; Shalini V. Sabarwal | Zendy; Thomas Severin | Zendy; Peter Szecsödy | Zendy; Claudio Gimpelewicz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Serelaxin in Patients with Acute Heart Failure

Author(s) -

Marco Metra,

John R. Teerlink,

Gad Cotter,

Beth A. Davison,

G. Michael Felker,

Gerasimos Filippatos,

Barry Greenberg,

Peter S. Pang,

Piotr Ponikowski,

Adriaan A. Voors,

Kirkwood F. Adams,

Stefan D. Anker,

Alexandra AriasMendoza,

Patricio Avendaño,

Fernando Bacal,

Michael Böhm,

Guillermo Bortman,

John G.F. Cleland,

Alain CohenSolal,

María G. CrespoLeiro,

Maria Dorobanţu,

Luis Eduardo Echeverría,

Roberto Ferrari,

Sorel Goland,

Eva Gonçalvesová,

Assen Goudev,

Lars Køber,

Juan Lema-Osores,

Phillip D. Levy,

Kenneth McDonald,

Pravin Manga,

Béla Merkely,

Christian Mueller,

Burkert Pieske,

José SilvaCardoso,

Jindřich Špinar,

Iain Squire,

Janina Stępińska,

W. Van Mieghem,

Dirk von Lewinski,

Gerhard Wikström,

Mehmet Birhan Yılmaz,

Nicole Hagner,

Thomas Holbro,

Tsushung A. Hua,

Shalini V. Sabarwal,

Thomas Severin,

Peter Szecsödy,

Claudio Gimpelewicz

Publication year - 2019

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1801291

Subject(s) - medicine , heart failure , placebo , hazard ratio , blood pressure , cardiology , confidence interval , alternative medicine , pathology

Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research